In p53 wildtype prostate cancer cells, pterostilbene prevented cell cycle progression at the G1 phase by inducing p53 expression and upregulating p21 expression maintaining tight control of proliferation; however, in p53 negative PC3 cells, pterostilbene induced apoptosis [94]. Here, TP53 is linked to prostate cancer.